We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gentle Tangential Flow Filtration System Safeguards Fragile Biotech Products

By LabMedica International staff writers
Posted on 15 Feb 2010
Many biotechnical processes require the separation of target molecules from a complex matrix of starting materials including growth media and cell lysates, and a new tangential flow filtration (TFF) system makes such separations easier and faster.

A separation system utilizing vibrating membrane filtration (VMF) technology and encapsulated hydrophilic polyethersulfone membrane filter modules has been introduced recently by Pall Corporation (Port Washington, NY, USA), a major producer of filtration, separation, and purification products.

The new PallSep Biotch System is recommended for the gentle separation of target molecules from complex process fluids containing high levels of biomass or particulates and high viscosity. More...
The shear forces generated by VMF are limited to a narrow layer on the membrane surface, ensuring that the bulk of the process fluid is not exposed to the shear. In addition, the required cross flow is much lower when compared to other TFF technologies. The system allows for a dynamic membrane filtration with lower energy input and gentle processing of the target molecule with a low-pressure drop.

The PallSep Biotech System consists of encapsulated 0.2-micron polyethersulfone (PES) filter modules with filter areas of 0.2, 1, and 5 square meters, which allow for process development and full-scale production.

The PallSep Biotech System employs an offset motor that induces oscillation of two masses (the membrane module and a seismic plate) connected by a torsion rod. Operation near the resonance frequency of about 50 Hz requires a very low energy input to maintain the oscillation of the two masses. The oscillation prevents particulates from accumulating at the membrane surface and thus fouling the membrane surface. A stable permeate flow is maintained while achieving high levels of product transmission, even with high particulate density and viscosity.

In order to satisfy customer-specific requirements, the PallSep Biotech System includes all the valves, pumps, sensors, vessel, and piping elements mounted on a skid assembly to operate the unit, either in manual or automated conditions.
"The new PallSep Biotech system expands processing options by allowing users to combine different process steps such as harvest and clarification within the same system, thus simplifying the process design,” said Nathalie Pathier, TFF product manager at Pall Life Sciences. "The stable permeate flow and improved protein transmission that we can achieve with this technology contributes to better process economics.”

Related Links:

Pall Corporation



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.